Nadya Merchant

Dr. Merchant has extensive experience with the design and implementation of clinical trials. She has been intrinsically involved in clinical trial regulatory affairs and takes a key role in formulating the preclinical drug development plan for Carmel Biosciencescompounds. As the Chief Commercialization Officer, Dr. Merchant is actively involved in developing the commercialization strategies for Carmel Biosciencescompounds through vital partnerships with larger pharmaceutical companies. Dr. Merchant received her doctorate in Nutrition from the Graduate School of Arts and Sciences at Emory University. She has a Masters degree in Public Health and International Nutrition from the Rollins School of Public Health. Her research focused on the effects of lipid-modifying and oxidative compounds on atherosclerosis development. Her background and expertise in human nutrition gives the company a valuable advantage in the nutraceutical arena. She has nearly ten years of experience in drug development. She has presented at various conferences including those of the American Heart Association, American College of Cardiology, The Southeast Lipid Research Conference and The Oxygen Society and has a number of publications.